Technology Offerings

HPV Vaccine Innovation: Bacterial Cells Transform Treatment

Cervical cancer is one of the most common cancers in women worldwide and the incidence correlates with HPV (human Papillomavirus) infection. The two commercially available vaccines against HPV only protect against new infections (prophylactic vaccination), whereas existing infections are not cleared. The current technology provides a vaccine with the capability to function both as a prophylactic and a therapeutic vaccine. Moreover, it can be produced in bacterial cells, which makes production very cost-effective.

Further Information: PDF

Deutsches Krebsforschungszentrum DKFZ
Phone: +49-6221-42 2955

Contact
Dr. Ruth Herzog

Comments (0)

Write a comment